Forefront Analytics’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-12,290
Closed -$121K 69
2021
Q1
$121K Sell
12,290
-782
-6% -$6.45K 0.05% 59
2020
Q4
$58K Sell
13,072
-4,130
-24% -$18.7K 0.03% 61
2020
Q3
$71K Sell
17,202
-278
-2% -$1.98K 0.03% 55
2020
Q2
$155K Buy
+17,480
New +$88.3K 0.1% 50

Other funds holding DVAX

Forefront Analytics's DVAX Position: Q2 2021 in Review

Forefront Analytics sold out of Dynavax Technologies (DVAX) in Q2 2021, closing a stake of 12,290 shares — an estimated $121K sold.

Forefront Analytics first reported a position in DVAX in Q2 2020 and held it in 4 quarters. The position peaked at $155K in Q2 2020. 154 funds tracked by Wall St. Rank hold DVAX as of Q2 2021.

  • Forefront Analytics reported no remaining Dynavax Technologies position as of Q2 2021 after selling out during the quarter.
  • Forefront Analytics sold 12,290 Dynavax Technologies shares in Q2 2021, an estimated $121K.
  • Forefront Analytics first reported a position in Dynavax Technologies in Q2 2020 and held it in 4 quarters.
  • Forefront Analytics's Dynavax Technologies position peaked at $155K in Q2 2020.
  • 154 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2021.

Based on Forefront Analytics's 13F filing for Q2 2021, filed 10 Aug 2021.